Abiopharma

🔍 Nygaard James P Jr (Executive)

Company: Core Scientific, Inc./tx (CORZ)

Report Date: 2026-03-17

Detailed Transactions and Holdings:

• Sold 92,725 shares of Common Stock at $16.42 per share (Direct)
  Date: 2026-03-17 | Code: F | equity_swap_involved: false | shares_owned_after: 928,928.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.
• F2: Reported amount reflects the acquisition of 3,555 shares of Common Stock and the acquisition of 336 shares of Common Stock that the Reporting Person received on July 17, 2025 and December 24, 2025, respectively, for no consideration in connection with in-kind distributions by XMS XPDI Sponsor Holdings LLC, which were exempt from Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16a-9 under the Exchange Act.